24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Migraine
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:55
Anthropic’s employee bill hit $1.7 billion in one quarter, or $107,000 per worker each month
12:11
After $30 million in losses, Arkia faces a battle over who will pay for its rescue
12:00
“My biggest concern is that organizations will give agents the ability to act faster and only then develop the ability to govern those actions”
10:20
X and Instagram account for 98% of views of antisemitic content in new study
More stories
Buzz
Most popular
Daily
Weekly
1
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
2
ServiceNow CEO says acquired Israeli startup Sweep helps it switch CRM customers in weeks, not years
3
Israeli digital health company TailorMed acquired in $250 million deal
4
Perion to be acquired by India’s Affle for $420 million, marking a steep fall for a once-billion-dollar Israeli company
5
Intel’s Israeli workers fear another downturn after stock collapse and deadly factory blast
More news
Migraine
11 stories about Migraine
Theranica secures $45 million Series C to treat migraines
29.08.22
|
CTech
The Israeli company has developed an FDA-cleared, smartphone-controlled, drug-free wearable device named Nerivio for the treatment of episodic and chronic migraine
Teva Receives FDA Approval for Migraine Autoinjector
29.01.20
|
Sophie Shulman
Teva’s anti-migraine injection was approved in late 2018 but struggled to establish a market share due to both Amgen and Eli Lilly offering a similar drug with an autoinjector
Teva’s Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing
17.11.19
|
Navit Zomer
The Israeli drugmaker’s manufacturing facility in Kfar Saba, already experienced with manufacturing cash cow Copaxone, will oversee the process of filling the syringes with the biological drug and also conduct quality control tests
This Headset Could Treat Migraines
14.07.19
|
Lilach Baumer
Israel-based Neurolief has recently received European approval for its noninvasive, adjustable electronic headset, which uses nerve stimulation to control pain
Teva Discontinues Development of Cluster Headache Drug
24.04.19
|
Tzally Greenberg
Under Teva’s brand name Ajovy, fremanezumab has already been approved in the U.S. and Europe as a preventative migraine treatment
Market Indifferent to European Approval of Teva's Migraine Drug
02.04.19
|
Lilach Baumer
Teva's injection, one of three similar migraine drugs already approved in the U.S., is the third to receive European approval after Amgen Inc. and Novartis AG and Eli Lilly
Migraine Treatment Startup Theranica Raises $35 Million
18.03.19
|
Adi Pick
Theranica develops electrical nerve stimulation (ENS) technology for controlling migraines
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports
27.01.19
|
Lilach Baumer
In October, American prescription benefits management company Express Scripts added Amgen and Eli Lilly’s drugs to its coverage but excluded Teva
U.S. Benefit Manager Express Scripts Snubs Teva Migraine Injection, Report Says
18.10.18
|
Lilach Baumer
A Wednesday Reuters report revealed the U.S. company will cover drugs by Eli Lilly and Amgen, but not by Teva
Teva Shares Rise Following FDA Approval of Migraine Drug
16.09.18
|
Dror Reich
Teva’s new migraine drug is forecasted to bring in $500 million in sales annually
Teva Submits Potential Moneymaker Migraine Drug for FDA Approval
18.10.17
|
Dror Reich and Lilach Baumer
Teva’s patent for its moneymaker multiple sclerosis drug Copaxone expired last year